BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7801059)

  • 21. Ankylosing spondylitis and bowel disease.
    Rudwaleit M; Baeten D
    Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesalazine in childhood inflammatory bowel disease.
    Barden L; Lipson A; Pert P; Walker-Smith JA
    Aliment Pharmacol Ther; 1989 Dec; 3(6):597-603. PubMed ID: 2577501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphasalazine in arthritis--an old drug rediscovered.
    Taggart AJ
    Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial.
    Haagsma CJ; van Riel PL; de Jong AJ; van de Putte LB
    Br J Rheumatol; 1997 Oct; 36(10):1082-8. PubMed ID: 9374925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfasalazine for ankylosing spondylitis.
    Chen J; Liu C
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004800. PubMed ID: 15846731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine.
    Das KM
    Postgrad Med; 1983 Dec; 74(6):141-8, 150-1. PubMed ID: 6139795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphasalazine: a review of 40 years' experience.
    Watkinson G
    Drugs; 1986; 32 Suppl 1():1-11. PubMed ID: 2877847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study.
    Bae JM; Choo JY; Kim KJ; Park KS
    Mod Rheumatol; 2017 May; 27(3):435-440. PubMed ID: 27459267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease.
    Dekker-Saeys BJ; Meuwissen SG; Van Den Berg-Loonen EM; De Haas WH; Agenant D; Tytgat GN
    Ann Rheum Dis; 1978 Feb; 37(1):33-5. PubMed ID: 629601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 33. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Effects of sulphasalazine (Salazopyrin) on faecal flora in patients with inflammatory bowel disease.
    Lendrum R; Walker JG; West B; Hill MJ
    Gut; 1974 Apr; 15(4):344. PubMed ID: 4151868
    [No Abstract]   [Full Text] [Related]  

  • 36. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
    Cooper R; Fraser SM; Sturrock RD; Gemmell CG
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (salazopyrin) in HLA-B27 related reactive arthritis.
    Mielants H; Veys EM
    J Rheumatol; 1985 Apr; 12(2):287-93. PubMed ID: 2863376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gram-negative bacteria, HLA-B27 and inflammatory bowel disease.
    Pease PE; Lane MR; Chahal H; Tallack JE; Allan RN
    Br J Rheumatol; 1988; 27 Suppl 2():29-31. PubMed ID: 3261188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study].
    Liu T; Wang XR; An Y; Zhou YS; Zhang XY; Duan TJ; Zhu JX; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu XY; Sun L; Chen HY; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai P; Li XF; Song LJ; Wang Y; Wang XY; Mu R; Su Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):188-94. PubMed ID: 22516985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulphasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients.
    Dougados M; Boumier P; Amor B
    Br Med J (Clin Res Ed); 1986 Oct; 293(6552):911-4. PubMed ID: 2876744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.